Approval · Notice of Compliance 4915 · 2004
VFEND: Notice of Compliance 4915
Issued August 20, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4915
- Date
- August 20, 2004
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antifungal agent
Products in this notice
Medicinal ingredients
- VORICONAZOLE 200 MG per TAB
- VORICONAZOLE 200 MG per VIAL
- VORICONAZOLE 50 MG per TAB